FluMist: An Intranasal Live Influenza Vaccine - Addendum

The Medical Letter on Drugs and Therapeutics

FROM
ISSUE

1176

February 16, 2004

View Complete Issue Table of Contents 2019

FluMist: An Intranasal Live Influenza Vaccine - Addendum

Show Related
Terms Hide Related
Terms

View Complete Issue

Send Article Feedback

Med Lett Drugs Ther. 2004 Feb 16;46(1176):16

Disclosures

Objective(s)

Select a term to see related articles Flumist immunization influenza Influenza vaccines vaccines

SUMMARY: Addendum: FluMist Storage: The storage requirements for FluMist, the intranasal live-attenuated influenza vaccine (Medical Letter 2003; 45:65) have changed. New data have shown that frost-free freezers are appropriate for storage for at least 3 months, without need for a freezer-box insert.

The Medical Letter, Inc. does not warrant that all the material in this publication is accurate and complete in every respect. The Medical Letter, Inc. and its editors shall not be held responsible for any damage resulting from any error, inaccuracy, or omission.

This article has been freely provided.